JPH05501401A - 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法 - Google Patents

組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法

Info

Publication number
JPH05501401A
JPH05501401A JP2513027A JP51302790A JPH05501401A JP H05501401 A JPH05501401 A JP H05501401A JP 2513027 A JP2513027 A JP 2513027A JP 51302790 A JP51302790 A JP 51302790A JP H05501401 A JPH05501401 A JP H05501401A
Authority
JP
Japan
Prior art keywords
lactobacillus
herpes simplex
pathogenic
simplex virus
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2513027A
Other languages
English (en)
Japanese (ja)
Inventor
ブルネル、フィリップ・アルフレッド
Original Assignee
シーダーズ―サイナイ・メディカル・センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シーダーズ―サイナイ・メディカル・センター filed Critical シーダーズ―サイナイ・メディカル・センター
Publication of JPH05501401A publication Critical patent/JPH05501401A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Semiconductor Lasers (AREA)
  • Spark Plugs (AREA)
JP2513027A 1989-11-01 1990-08-30 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法 Pending JPH05501401A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/430,491 US5149532A (en) 1989-11-01 1989-11-01 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
US430,491 1989-11-01

Publications (1)

Publication Number Publication Date
JPH05501401A true JPH05501401A (ja) 1993-03-18

Family

ID=23707776

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2513027A Pending JPH05501401A (ja) 1989-11-01 1990-08-30 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法

Country Status (8)

Country Link
US (1) US5149532A (de)
EP (1) EP0498804B1 (de)
JP (1) JPH05501401A (de)
AT (1) ATE149569T1 (de)
CA (1) CA2072657A1 (de)
DE (1) DE69030099T2 (de)
ES (1) ES2100893T3 (de)
WO (1) WO1991006654A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
PT652758E (pt) * 1992-06-18 2000-04-28 Harvard College Vacinas de toxina da difteria
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
AU774535B2 (en) * 1995-10-20 2004-07-01 Actogenix Nv Delivery of biologically active polypeptides
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) * 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
AU2003298291A1 (en) * 2002-11-15 2004-06-15 Universiteit Gent Self-containing lactobacillus strain
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
WO2008090223A2 (en) 2007-01-25 2008-07-31 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
HRP20181102T1 (hr) 2012-05-16 2018-09-07 Immune Design Corp Cjepiva za hsv-2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
PT77014B (en) * 1982-07-20 1986-01-24 Molecular Genetics Inc Production of herpes simplex viral proteins
WO1985003521A1 (en) * 1984-02-01 1985-08-15 Enterovax Research Pty. Ltd. Bacterial strains
NL8503316A (nl) * 1985-11-29 1987-06-16 Stichting Nl I Zuivelonderzoek Werkwijze voor het bereiden van proteinen met behulp van gastheer-organismen, in het bijzonder melkzuurbacterien, welke recombinant dna-plasmiden met een hoge replicon-aktiviteit en een hoge promotor-aktiviteit voor het betreffende proteine-coderende gen bevatten, de van dergelijke recombinant dna-plasmiden voorziene gastheerorganismen, de recombinant dna-plasmiden zelve, de replicon-aktiviteit en promotor-aktiviteit coderende dna-fragmenten, alsmede de verkregen proteinen.
EP0319690A1 (de) * 1987-11-24 1989-06-14 Nisshin Flour Milling Co., Ltd. Verfahren zum Einbringen von Fremd-DNA in bestimmten Bakterien

Also Published As

Publication number Publication date
EP0498804A4 (en) 1992-12-09
EP0498804B1 (de) 1997-03-05
ES2100893T3 (es) 1997-07-01
EP0498804A1 (de) 1992-08-19
US5149532A (en) 1992-09-22
DE69030099D1 (de) 1997-04-10
WO1991006654A1 (en) 1991-05-16
ATE149569T1 (de) 1997-03-15
DE69030099T2 (de) 1997-07-31
CA2072657A1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
EP0390799B1 (de) Respiratorisches syncytiales virus, impstoffe
Igietseme et al. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein–lipophilic immune response-stimulating complexes
Tan et al. Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein
Di-qiu et al. High-level mucosal and systemic immune responses induced by oral administration with Lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with Lactobacillus-expressed N protein
Mumford et al. Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8)
JPH06505392A (ja) 弱毒化され、遺伝子的に加工されたシュードラビーウイルスｓ−ｐｒｖ−１５５およびその使用
EP0189958B1 (de) Hundeparvovirus-Impfstoffe
US4517304A (en) Production of viral antigens
Vishwanath et al. A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever
JP2004529854A (ja) 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
JPH05501401A (ja) 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法
CN104894045B (zh) 一种共表达口蹄疫病毒vp1基因与免疫佐剂牛il-6基因的重组乳酸杆菌及其制备方法和应用
Hamparian et al. Laboratory and field investigations of bovine myxovirus parainfluenza 3 virus and vaccine: III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle
Jameson et al. Natural variants of the Sabin type 1 vaccine strain of poliovirus and correlation with a poliovirus neutralization site
Lee et al. Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase
Epstein Vaccination against Epstein-Barr virus: current progress and future strategies
Butchko et al. Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses
RU2699671C1 (ru) Вакцина для ранней защиты против ящура типа О инактивированная эмульсионная
Reciilard Cell-culture vaccines for veterinary use
Roivainen et al. Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice
Choi et al. Long-term egg-yolk adaptation of the Orientia tsutsugamushi for preparation of a formalinized immunogen
Thirkell et al. The humoral immune response of lambs experimentally infected with Mycoplasma ovipneumoniae
Holper et al. Further studies on multiplication, serology and antigenicity of 2060 and JH viruses
TAKADA et al. Protection of mice against Aujeszky's disease virus infection by intranasal vaccination with inactivated virus
Bar-Joseph et al. Booster immunization with a partially purified citrus tristeza virus (CTV) preparation after priming with recombinant CTV coat protein enhances the binding capacity of capture antibodies by ELISA